Guyan Liang

551 total citations
24 papers, 343 citations indexed

About

Guyan Liang is a scholar working on Molecular Biology, Organic Chemistry and Genetics. According to data from OpenAlex, Guyan Liang has authored 24 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Organic Chemistry and 5 papers in Genetics. Recurrent topics in Guyan Liang's work include Chemical Synthesis and Analysis (5 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers) and Synthesis and Biological Evaluation (4 papers). Guyan Liang is often cited by papers focused on Chemical Synthesis and Analysis (5 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers) and Synthesis and Biological Evaluation (4 papers). Guyan Liang collaborates with scholars based in United States, France and Mexico. Guyan Liang's co-authors include J. Phillip Bowen, Yaoming Xie, Henry F. Schaefer, Henry W. Pauls, Magali Mathieu, Jennifer Cairns, Thaddeus R. Nieduzak, Sam Rebello, Yong Mi Choi-Sledeski and Suzanne C. Aldous and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Computational Chemistry.

In The Last Decade

Guyan Liang

23 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guyan Liang United States 13 163 119 43 42 37 24 343
Haresh Ajani Czechia 13 201 1.2× 155 1.3× 67 1.6× 20 0.5× 76 2.1× 19 413
Martin Morgenthaler Switzerland 6 328 2.0× 222 1.9× 61 1.4× 16 0.4× 57 1.5× 6 576
David D. Davey United States 11 170 1.0× 154 1.3× 17 0.4× 38 0.9× 15 0.4× 17 381
U. Obst Switzerland 11 322 2.0× 164 1.4× 124 2.9× 14 0.3× 152 4.1× 13 508
Margaret A. McCarrick United States 11 389 2.4× 108 0.9× 34 0.8× 17 0.4× 73 2.0× 12 545
Darin A. Allen United States 8 146 0.9× 186 1.6× 19 0.4× 38 0.9× 20 0.5× 10 377
Miles A. Fabian United States 11 233 1.4× 208 1.7× 118 2.7× 8 0.2× 81 2.2× 14 466
Volkmar Wehner Germany 14 313 1.9× 303 2.5× 70 1.6× 34 0.8× 212 5.7× 26 769
Masanori Miura Japan 13 553 3.4× 93 0.8× 24 0.6× 22 0.5× 69 1.9× 25 810
Robert J. Weinkam United States 15 134 0.8× 208 1.7× 150 3.5× 15 0.4× 35 0.9× 31 500

Countries citing papers authored by Guyan Liang

Since Specialization
Citations

This map shows the geographic impact of Guyan Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guyan Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guyan Liang more than expected).

Fields of papers citing papers by Guyan Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guyan Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guyan Liang. The network helps show where Guyan Liang may publish in the future.

Co-authorship network of co-authors of Guyan Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Guyan Liang. A scholar is included among the top collaborators of Guyan Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guyan Liang. Guyan Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Guyan & J. Phillip Bowen. (2016). Development of Trypsin-Like Serine Protease Inhibitors as Therapeutic Agents: Opportunities, Challenges, and their Unique Structure-Based Rationales. Current Topics in Medicinal Chemistry. 16(13). 1506–1529. 15 indexed citations
2.
Liang, Guyan, Yong Mi Choi-Sledeski, Xin Chen, et al.. (2012). A β-tryptase inhibitor with a tropanylamide scaffold to improve in vitro stability and to lower hERG channel binding affinity. Bioorganic & Medicinal Chemistry Letters. 22(4). 1606–1610. 12 indexed citations
3.
Liang, Guyan, Xin Chen, Suzanne C. Aldous, et al.. (2012). Human kallikrein 6 inhibitors with a para-amidobenzylanmine P1 group identified through virtual screening. Bioorganic & Medicinal Chemistry Letters. 22(7). 2450–2455. 16 indexed citations
4.
Liang, Guyan, Yong Mi Choi-Sledeski, Xin Chen, et al.. (2012). Dimerization of β-tryptase inhibitors, does it work for both basic and neutral P1 groups?. Bioorganic & Medicinal Chemistry Letters. 22(9). 3370–3376. 6 indexed citations
5.
Liang, Guyan, Xin Chen, Suzanne C. Aldous, et al.. (2012). Virtual Screening and X-ray Crystallography for Human Kallikrein 6 Inhibitors with an Amidinothiophene P1 Group. ACS Medicinal Chemistry Letters. 3(2). 159–164. 11 indexed citations
6.
Liang, Guyan, Suzanne C. Aldous, Julian Levell, et al.. (2011). Structure-based library design and the discovery of a potent and selective mast cell β-tryptase inhibitor as an oral therapeutic agent. Bioorganic & Medicinal Chemistry Letters. 22(2). 1049–1054. 16 indexed citations
7.
Liang, Guyan, Kent Neuenschwander, Lin‐Li Wei, et al.. (2011). Structure-based design, synthesis, and profiling of potent and selective neuronal nitric oxide synthase (nNOS) inhibitors with an amidinothiophene hydroxypiperidine scaffold. MedChemComm. 2(3). 201–201. 4 indexed citations
8.
9.
Liang, Guyan, Yong Mi Choi-Sledeski, Xin Chen, et al.. (2010). A conformationally constrained inhibitor with an enhanced potency for β-tryptase and stability against semicarbazide-sensitive amine oxidase (SSAO). Bioorganic & Medicinal Chemistry Letters. 20(22). 6721–6724. 8 indexed citations
10.
Hopkins, Corey R., Steven S. Kaye, Henry W. Pauls, et al.. (2005). Design, synthesis, and biological activity of potent and selective inhibitors of mast cell tryptase. Bioorganic & Medicinal Chemistry Letters. 15(11). 2734–2737. 29 indexed citations
11.
Jackson, Sharon, Thaddeus R. Nieduzak, Guyan Liang, et al.. (2005). Design, synthesis and characterization of a novel class of coumarin-based inhibitors of inducible nitric oxide synthase. Bioorganic & Medicinal Chemistry. 13(8). 2723–2739. 29 indexed citations
12.
Hopkins, Corey R., Kent Neuenschwander, Sharon Jackson, et al.. (2004). Novel pyrazinone inhibitors of mast cell tryptase: synthesis and SAR evaluation. Bioorganic & Medicinal Chemistry Letters. 14(19). 4819–4823. 20 indexed citations
13.
Liang, Guyan, et al.. (2002). Molecular mechanics (MM4) force field development for phosphine and its alkyl derivatives. Chirality. 14(2-3). 220–231. 5 indexed citations
14.
Gong, Yong, Henry W. Pauls, Alfred P. Spada, et al.. (2000). Amido-(propyl and allyl)-hydroxybenzamidines: development of achiral inhibitors of factor Xa. Bioorganic & Medicinal Chemistry Letters. 10(3). 217–221. 9 indexed citations
15.
Liang, Guyan, et al.. (2000). Molecular mechanics (MM3) parameterization for oxocarbenium ions. Journal of Computational Chemistry. 21(5). 329–339. 6 indexed citations
16.
Choi-Sledeski, Yong Mi, Michael R. Becker, William R. Ewing, et al.. (1999). Aminoisoquinolines: Design and synthesis of an orally active benzamidine isostere for the inhibition of factor XA. Bioorganic & Medicinal Chemistry Letters. 9(17). 2539–2544. 20 indexed citations
17.
Liang, Guyan, et al.. (1997). Ab initio calculations and molecular mechanics (MM3) force field development for ammonium and protonated aliphatic amines. Journal of Computational Chemistry. 18(11). 1371–1391. 4 indexed citations
18.
Liang, Guyan, et al.. (1997). Ab initio calculations and molecular mechanics (MM3) force field development for sulfonamide and its alkyl derivatives. Journal of Molecular Structure THEOCHEM. 401(1-2). 165–179. 19 indexed citations
19.
Liang, Guyan, et al.. (1996). Parameter analysis and refinement toolkit system and its application in MM3 parameterization for phosphine and its derivatives. Journal of Computational Chemistry. 17(8). 940–953. 22 indexed citations
20.
Liang, Guyan, et al.. (1994). Molecular mechanics (MM3) parameterization of hydroxylamine and methyl derivatives. Journal of Computational Chemistry. 15(8). 866–874. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haresh Ajani Breakdown of academic impact, for papers by Martin Morgenthaler Breakdown of academic impact, for papers by David D. Davey Breakdown of academic impact, for papers by U. Obst Breakdown of academic impact, for papers by Margaret A. McCarrick Breakdown of academic impact, for papers by Darin A. Allen Breakdown of academic impact, for papers by Miles A. Fabian Breakdown of academic impact, for papers by Volkmar Wehner Breakdown of academic impact, for papers by Masanori Miura Breakdown of academic impact, for papers by Robert J. Weinkam
Rankless by CCL
2026